Westlake Chemical PRN(WLKP)
$20.99-0.10 (-0.47%)
WLKP
Westlake Chemical PRN financials statements
$20.99
At close:-0.10 (-0.47%)
Want to see WLKP full AI Analyst Report?
Westlake Chemical PRN (WLKP) Ratios
284 Followers
Westlake Chemical PRN Ratios
WLKP's free cash flow for Q3 2026 was $110.47M. For the 2026 fiscal year, WLKP's free cash flow was decreased by $-11.69M and operating cash flow was $122.16M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.80 | 4.35 | 4.02 | 3.67 | 2.63 |
| Quick Ratio | 2.74 | 4.28 | 3.94 | 3.60 | 2.55 |
| Cash Ratio | 0.86 | 1.05 | 1.04 | 0.97 | 0.16 |
| Solvency Ratio | 0.39 | 0.38 | 0.36 | 0.40 | 0.38 |
| Operating Cash Flow Ratio | 5.47 | 8.76 | 8.02 | 6.93 | 3.82 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -310.68M | $ -217.72M | $ -234.39M | $ -222.48M | $ -226.79M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.31 | 0.30 | 0.29 | 0.27 |
| Debt-to-Equity Ratio | 0.80 | 0.77 | 0.76 | 0.75 | 0.74 |
| Debt-to-Capital Ratio | 0.44 | 0.44 | 0.43 | 0.43 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.44 | 0.44 | 0.43 | 0.43 | 0.43 |
| Financial Leverage Ratio | 2.51 | 2.48 | 2.52 | 2.57 | 2.76 |
| Debt Service Coverage Ratio | 19.63 | 19.72 | 17.79 | 35.00 | 58.87 |
| Interest Coverage Ratio | 13.96 | 15.19 | 13.50 | 25.93 | 46.58 |
| Debt to Market Cap | 0.60 | 0.49 | 0.52 | 0.48 | 0.42 |
| Interest Debt Per Share | 11.99 | 12.07 | 12.09 | 11.73 | 11.60 |
| Net Debt to EBITDA | 0.79 | 0.67 | 0.72 | 0.71 | 0.74 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.81% | 36.88% | 32.54% | 23.69% | 36.36% |
| EBIT Margin | 27.60% | 34.84% | 30.39% | 21.92% | 33.81% |
| EBITDA Margin | 38.57% | 44.69% | 39.65% | 29.52% | 42.77% |
| Operating Profit Margin | 27.39% | 34.37% | 30.04% | 21.82% | 33.81% |
| Pretax Profit Margin | 25.64% | 32.57% | 28.17% | 21.08% | 33.08% |
| Net Profit Margin | 4.17% | 5.49% | 4.56% | 4.03% | 6.79% |
| Continuous Operations Profit Margin | 25.59% | 32.50% | 28.10% | 21.02% | 33.04% |
| Net Income Per EBT | 16.28% | 16.86% | 16.18% | 19.11% | 20.54% |
| EBT Per EBIT | 93.60% | 94.76% | 93.77% | 96.59% | 97.87% |
| Return on Assets (ROA) | 3.88% | 4.84% | 4.12% | 4.68% | 5.57% |
| Return on Equity (ROE) | 9.72% | 12.03% | 10.39% | 12.01% | 15.38% |
| Return on Capital Employed (ROCE) | 26.52% | 31.68% | 28.38% | 26.64% | 29.89% |
| Return on Invested Capital (ROIC) | 26.47% | 31.61% | 28.31% | 26.56% | 29.85% |
| Return on Tangible Assets | 3.89% | 4.87% | 4.14% | 4.70% | 5.60% |
| Earnings Yield | 7.27% | 7.65% | 7.11% | 7.75% | 8.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 18.35 | 6.38 | 7.32 | 14.55 | 4.77 |
| Payables Turnover | 15.96 | 34.56 | 25.62 | 24.61 | 16.84 |
| Inventory Turnover | 295.72 | 176.68 | 181.26 | 257.85 | 86.89 |
| Fixed Asset Turnover | 1.32 | 1.26 | 1.26 | 1.61 | 1.16 |
| Asset Turnover | 0.93 | 0.88 | 0.90 | 1.16 | 0.82 |
| Working Capital Turnover Ratio | 8.40 | 6.39 | 6.83 | 9.02 | 6.11 |
| Cash Conversion Cycle | -1.74 | 48.74 | 37.64 | 11.67 | 59.10 |
| Days of Sales Outstanding | 19.89 | 57.23 | 49.87 | 25.09 | 76.57 |
| Days of Inventory Outstanding | 1.23 | 2.07 | 2.01 | 1.42 | 4.20 |
| Days of Payables Outstanding | 22.87 | 10.56 | 14.25 | 14.83 | 21.67 |
| Operating Cycle | 21.12 | 59.30 | 51.89 | 26.50 | 80.77 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.96 | 13.77 | 12.82 | 13.17 | 11.60 |
| Free Cash Flow Per Share | 5.72 | 12.38 | 11.49 | 11.63 | 9.30 |
| Dividend Paid and CapEx Coverage Ratio | 1.93 | 4.20 | 3.99 | 3.85 | 2.77 |
| Capital Expenditure Coverage Ratio | 3.56 | 9.90 | 9.65 | 8.57 | 5.03 |
| Operating Cash Flow Coverage Ratio | 0.70 | 1.21 | 1.13 | 1.16 | 1.02 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.43 | 0.38 | 0.29 | 0.34 |
| Free Cash Flow Yield | 30.12% | 53.48% | 53.09% | 49.49% | 34.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.77 | 13.07 | 14.06 | 12.90 | 11.46 |
| Price-to-Sales (P/S) Ratio | 0.57 | 0.72 | 0.64 | 0.52 | 0.78 |
| Price-to-Book (P/B) Ratio | 1.34 | 1.57 | 1.46 | 1.55 | 1.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.32 | 1.87 | 1.88 | 2.02 | 2.89 |
| Price-to-Operating Cash Flow Ratio | 2.39 | 1.68 | 1.69 | 1.78 | 2.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.62 | 0.88 | -0.17 | -0.78 | 0.65 |
| Enterprise Value Multiple | 2.28 | 2.28 | 2.34 | 2.47 | 2.56 |
| Enterprise Value | 1.02B | 1.16B | 1.10B | 1.16B | 1.33B |
| EV to EBITDA | 2.28 | 2.28 | 2.34 | 2.47 | 2.56 |
| EV to Sales | 0.88 | 1.02 | 0.93 | 0.73 | 1.09 |
| EV to Free Cash Flow | 5.08 | 2.65 | 2.73 | 2.84 | 4.06 |
| EV to Operating Cash Flow | 3.65 | 2.38 | 2.44 | 2.51 | 3.25 |
| Tangible Book Value Per Share | 22.61 | 23.37 | 24.13 | 25.50 | 27.46 |
| Shareholders’ Equity Per Share | 14.22 | 14.72 | 14.82 | 15.18 | 15.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 33.11 | 32.24 | 33.78 | 45.24 | 34.51 |
| Net Income Per Share | 1.38 | 1.77 | 1.54 | 1.82 | 2.34 |
| Tax Burden | 0.16 | 0.17 | 0.16 | 0.19 | 0.21 |
| Interest Burden | 0.93 | 0.94 | 0.93 | 0.96 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.03 | 0.02 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.94 | 1.31 | 8.33 | 1.38 | 1.02 |
Currency in USD

